srx news american journal of oncology
Access to the just released American Journal of Oncology and Hematologyis being picked up by medical profession as Sir Spheres having widespread implications in being used as standard of care in adjuvant therapy for metastaic disease to the liver with newer generation chemo drugs. This means Sir Spheres has widespread implications for revenues for Sirtex medical as this is a multi billion dollar market potential and market cap of entire co of SRX is only 90 million USD. Tjis means that at current share price ther is potential 10 bagger for sp as Hunter hall originally projected 3 yrs ago as they are now saying they will be right on price but were 3 yrs premature in 2003. HH predicting very large sp increase.Even medical professionals buying a few shares could make sp move quickly and up as float is only 8 million.Before i was adding on bid, but now i am sensing there are many buyers adding on ask.
SRX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held